Cargando…

端粒与端粒酶研究在肺癌中的临床应用前景与挑战

Lung cancer is one of the malignant tumors with high incidence rate and high mortality worldwide. Telomere and telomerase are closely related to the occurrence and development of lung cancer. Although telomerase may not be the direct cause of carcinogenesis, it plays a key role in maintaining telome...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849035/
https://www.ncbi.nlm.nih.gov/pubmed/33478187
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.45
_version_ 1783645236560396288
collection PubMed
description Lung cancer is one of the malignant tumors with high incidence rate and high mortality worldwide. Telomere and telomerase are closely related to the occurrence and development of lung cancer. Although telomerase may not be the direct cause of carcinogenesis, it plays a key role in maintaining telomere length and tumor growth. The length of most tumors, including lung cancer, is shortened. The change of telomere length is related to the risk of lung cancer, and may become the therapeutic target and predictive index. Target drugs for telomere and telomerase signaling pathway are constantly being explored, and drugs represented by telomerase inhibitors are expected to be used in clinical treatment of lung cancer in the future. However, the research on telomere and telomerase is far from enough. The bypass mechanism of telomere length maintenance may be the direction of further research.
format Online
Article
Text
id pubmed-7849035
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-78490352021-02-04 端粒与端粒酶研究在肺癌中的临床应用前景与挑战 Zhongguo Fei Ai Za Zhi 综述 Lung cancer is one of the malignant tumors with high incidence rate and high mortality worldwide. Telomere and telomerase are closely related to the occurrence and development of lung cancer. Although telomerase may not be the direct cause of carcinogenesis, it plays a key role in maintaining telomere length and tumor growth. The length of most tumors, including lung cancer, is shortened. The change of telomere length is related to the risk of lung cancer, and may become the therapeutic target and predictive index. Target drugs for telomere and telomerase signaling pathway are constantly being explored, and drugs represented by telomerase inhibitors are expected to be used in clinical treatment of lung cancer in the future. However, the research on telomere and telomerase is far from enough. The bypass mechanism of telomere length maintenance may be the direction of further research. 中国肺癌杂志编辑部 2021-01-20 /pmc/articles/PMC7849035/ /pubmed/33478187 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.45 Text en 版权所有©《中国肺癌杂志》编辑部2021 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 综述
端粒与端粒酶研究在肺癌中的临床应用前景与挑战
title 端粒与端粒酶研究在肺癌中的临床应用前景与挑战
title_full 端粒与端粒酶研究在肺癌中的临床应用前景与挑战
title_fullStr 端粒与端粒酶研究在肺癌中的临床应用前景与挑战
title_full_unstemmed 端粒与端粒酶研究在肺癌中的临床应用前景与挑战
title_short 端粒与端粒酶研究在肺癌中的临床应用前景与挑战
title_sort 端粒与端粒酶研究在肺癌中的临床应用前景与挑战
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849035/
https://www.ncbi.nlm.nih.gov/pubmed/33478187
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.45
work_keys_str_mv AT duānlìyǔduānlìméiyánjiūzàifèiáizhōngdelínchuángyīngyòngqiánjǐngyǔtiāozhàn
AT duānlìyǔduānlìméiyánjiūzàifèiáizhōngdelínchuángyīngyòngqiánjǐngyǔtiāozhàn
AT duānlìyǔduānlìméiyánjiūzàifèiáizhōngdelínchuángyīngyòngqiánjǐngyǔtiāozhàn